HUADE INSIGHTS | If In Ovo EGF Supplementation Has These Limitations, Does It Still Hold Any Value?

If In Ovo EGF Supplementation Has These Limitations, Does It Still Hold Any Value?

If we look only at the results, this paper might not seem "successful" — EGF entered the chicken embryo, and the receptor did respond, but the chicks' final growth performance did not show the improvement researchers had hoped for. If the story ended there, many people might be tempted to label it a "failed experiment." But genuine scientific research is never rendered worthless simply because its results fall short of expectations. Quite the opposite — many of the discoveries that have driven real progress in this industry began precisely with experiments that "didn't succeed."

Consider it from another angle: if this paper had ultimately proven that "EGF works extremely well," all we would have gained is a new product direction. But because it didn't produce the ideal outcome, it has instead left us with far more questions worth thinking through — Why did the receptor respond, yet production performance failed to improve? Why do different species produce different outcomes? Why might a single supplementation be insufficient to complete the entire regulatory process? These questions are worth far more to the industry's continued exploration than a simple "it works" or "it doesn't."

How Many Questions Must a Functional Substance Actually Answer?

In fact, the insight offered by this paper extends far beyond EGF itself. It reminds us that evaluating any functional bioactive substance requires answering at least four questions: Does it have a clearly defined mechanism of action? Does it have a corresponding target site? Can it reach that target through an appropriate delivery method? And finally — most importantly — can it ultimately be reliably translated into actual production performance? Many innovative technologies answer the first three questions quite well; the real difficulty lies in the fourth. Because animals are not laboratories, and a farm floor is not a petri dish — environment, diet, health status, management practices, and breed differences are all variables that can influence the final outcome.

In recent years, whether it's EGF, probiotics, postbiotics, bioactive peptides, or various plant extracts, we've seen an increasing number of exciting basic research findings. This research continually deepens our understanding of animal physiology and continually opens up new avenues for nutritional regulation. At the same time, however, it also serves as a reminder to the entire industry: scientific findings are not the same as mature products. Moving from the laboratory to the farm requires extensive validation, optimization, and iteration — which is precisely why truly mature products often take many years of accumulated effort to develop. Basic research answers the question of "whether something is possible"; industrial R&D answers the question of "how to achieve it reliably and consistently." The two are not in competition — they are different stages along the same chain of innovation. Only when basic research keeps raising new questions, and industrial R&D keeps finding new answers, can genuine innovation truly take place.

HUADE Technical Perspective

The original purpose of Huade Thursday has never been simply to introduce a research paper. What we hope to do, instead, is translate scientific findings into language the industry can understand, reflect on, and apply. Every paper is only a starting point — what truly matters is identifying the underlying questions within it, understanding the principles at work, and ultimately transforming those insights into solutions that drive the industry forward. These four articles — from the critical window of early-life development, to the recognition of the EGF signal, to the analysis of why a confirmed mechanism failed to translate into production performance — are, at their core, all telling the same story: what truly drives industry progress is not a single experimental result, but a scientific attitude that keeps asking "why." And it is precisely this attitude that builds a genuine bridge between basic research and industrial practice.